NCT02172573View on ClinicalTrials.gov

Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

July 31, 2000

Conditions
Parkinson Disease
Interventions
DRUG

Pramipexole

DRUG

Bromocriptine

DRUG

Placebo pramipexole

DRUG

Placebo bromocriptine

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02172573 - Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease | Biotech Hunter | Biotech Hunter